On Valeant's Planner: Congressional Testimony (Maybe) a New CEO and 10-K

Washington and Wall Street will have their sights on Valeant Pharmaceuticals International Inc. this upcoming week.

from WSJ.com: US Business http://ift.tt/1TnQEcv
via IFTTT